msctc-0010
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2017 (NCT03158896)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- msctc-0010
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04385056 | Phase 1 | Jul 1, 2020 | IMAC Holdings, Inc. |
| NCT03158896 | Phase 1 | Aug 1, 2017 | University of Kansas |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| IMAC Holdings, Inc. | For profit | 1 | 1 | 1 | 2020 |
| University of Kansas | Academic/Hospital | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1